adenosine has been researched along with Filoviridae Infections in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Babu, YS; Bantia, S; Bavari, S; Chen, X; Dong, L; Eaton, BP; Garza, NL; Honnold, S; Kotian, P; Minning, DM; Panchal, RG; Pegoraro, G; Retterer, CJ; Sheridan, WP; Stuthman, KS; Taubenheim, BR; Van Tongeren, SA; Warren, TK; Welch, LS; Wells, J | 1 |
Bray, N | 1 |
Falzarano, D; Feldmann, H | 1 |
Bray, M | 1 |
4 other study(ies) available for adenosine and Filoviridae Infections
Article | Year |
---|---|
Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430.
Topics: Adenine; Adenosine; Administration, Oral; Animals; Antiviral Agents; Disease Models, Animal; DNA-Directed RNA Polymerases; Ebolavirus; Filoviridae; Filoviridae Infections; Hemorrhagic Fever, Ebola; Humans; Injections, Intramuscular; Macaca fascicularis; Marburg Virus Disease; Marburgvirus; Purine Nucleosides; Pyrrolidines; RNA; Time Factors | 2014 |
Antiviral drugs: Spanner in the works of filovirus infection.
Topics: Adenosine; Animals; Antiviral Agents; Filoviridae; Filoviridae Infections; Humans; Purine Nucleosides | 2014 |
Possible leap ahead in filovirus therapeutics.
Topics: Adenosine; Animals; Antiviral Agents; Filoviridae; Filoviridae Infections; Humans; Purine Nucleosides | 2014 |
The role of the Type I interferon response in the resistance of mice to filovirus infection.
Topics: Adenosine; Animals; Animals, Suckling; Antibodies; Antiviral Agents; Disease Susceptibility; DNA-Binding Proteins; Filoviridae; Filoviridae Infections; Gene Deletion; Immunization; Injections, Intraperitoneal; Injections, Subcutaneous; Interferon Type I; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Mice, Knockout; Mice, SCID; Receptor, Interferon alpha-beta; Receptors, Interferon; Species Specificity; STAT1 Transcription Factor; Survival Rate; Trans-Activators; Virulence; Weight Loss | 2001 |